• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

文莱达鲁萨兰国结直肠癌患者的生存情况:2002-09 年与 2010-17 年的比较。

Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.

机构信息

PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Tungku Link Road, Bandar Seri Begawan, BE1410, Brunei Darussalam.

School of Medicine, National University of Ireland Galway, University Road, Galway, H91 TK33, Ireland.

出版信息

BMC Cancer. 2021 Apr 30;21(1):477. doi: 10.1186/s12885-021-08224-6.

DOI:10.1186/s12885-021-08224-6
PMID:33926405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086270/
Abstract

BACKGROUND

Colorectal cancer (CRC) is a major cause of cancer-related mortality worldwide. It is the second leading cause of cancer death in men and women in Brunei Darussalam in 2017, posing a major burden on society.

METHODS

This retrospective cohort study (n = 1035 patients diagnosed with CRC in Brunei Darussalam from 1st January 2002 until 31st December 2017) aims to compare the overall survival rates of CRC patients (2002-2017), to compare survival rates between two study periods (2002-2009 and 2010-2017) and to identify prognostic factors of CRC. Kaplan-Meier estimator and log-rank tests were performed to analyse the overall survival rates of CRC patients. Multiple Cox regression was performed to determine the prognostic factors of CRC with adjusted hazard ratios (Adj. HRs) reported.

RESULTS

The 1-, 3- and 5-year survival rates of CRC patients are 78.6, 62.5, and 56.0% respectively from 2002 to 2017. The 1-, 3-, and 5-year survival rates of CRC patients for 2002-2009 are 82.2, 69.6, and 64.7%; 77.0, 59.1, and 51.3% for 2010-2017 respectively. A significant difference in CRC patients' survival rate was observed between the two study periods, age groups, ethnic groups, cancer stages, and sites of cancer (p < 0.05). The Adjusted Hazard Ratios (Adj. HRs) were significantly higher in the 2010-17 period (Adj. HR = 1.78, p < 0.001), older age group ( ≥ 60 years) (Adj. HR = 1.93, p = 0.005), distant cancer (Adj. HR = 4.69, p < 0.010), tumor at transverse colon and splenic flexure of colon (Adj. HR = 2.44, p = 0.009), and lower in the Chinese(Adj. HR = 0.63, p = 0.003).

CONCLUSION

This study highlights the lower survival rates of CRC patients in 2010-2017, Malays, older patients, distant cancer, and tumors located at the latter half of the proximal colon (transverse colon), and predominantly LCRC (splenic flexure, descending colon, sigmoid colon, overlapping lesion colon and colon (NOS), as well as the rectosigmoid junction and rectum (NOS)). Age, ethnicity, cancer stage, and tumor location are significant prognostic factors for CRC. These findings underscore the importance of public health policies and programmes to enhance awareness on CRC from screening to developing strategies for early detection and management, to reduce CRC-associated mortality.

摘要

背景

结直肠癌(CRC)是全球癌症相关死亡的主要原因。2017 年,文莱达鲁萨兰国男性和女性因癌症死亡的第二大原因是结直肠癌,这给社会带来了重大负担。

方法

本回顾性队列研究(n=1035 名在文莱达鲁萨兰国诊断为 CRC 的患者,从 2002 年 1 月 1 日至 2017 年 12 月 31 日)旨在比较 CRC 患者的总生存率(2002-2017 年),比较两个研究期(2002-2009 年和 2010-2017 年)之间的生存率,并确定 CRC 的预后因素。采用 Kaplan-Meier 估计器和对数秩检验分析 CRC 患者的总生存率。采用多 Cox 回归分析确定 CRC 的预后因素,并报告调整后的危险比(Adj. HR)。

结果

2002 年至 2017 年 CRC 患者的 1、3 和 5 年生存率分别为 78.6%、62.5%和 56.0%。2002-2009 年 CRC 患者的 1、3 和 5 年生存率分别为 82.2%、69.6%和 64.7%;2010-2017 年分别为 77.0%、59.1%和 51.3%。两个研究期、年龄组、种族、癌症分期和癌症部位的 CRC 患者生存率存在显著差异(p<0.05)。2010-17 期间的调整后危险比(Adj. HR)显著升高(Adj. HR=1.78,p<0.001),年龄较大组(≥60 岁)(Adj. HR=1.93,p=0.005),远处癌症(Adj. HR=4.69,p<0.010),横结肠和结肠脾曲的肿瘤(Adj. HR=2.44,p=0.009),而中国人较低(Adj. HR=0.63,p=0.003)。

结论

本研究强调了 2010-2017 年 CRC 患者生存率较低、马来人、年龄较大的患者、远处癌症以及近端结肠后半部(横结肠)的肿瘤,主要是 LCRC(脾曲、降结肠、乙状结肠、重叠病变结肠和结肠(NOS),以及直肠乙状结肠交界处和直肠(NOS))。年龄、种族、癌症分期和肿瘤位置是 CRC 的重要预后因素。这些发现强调了公共卫生政策和计划的重要性,以提高对 CRC 的认识,从筛查到制定早期发现和管理策略,以降低 CRC 相关死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/00e2c93a0952/12885_2021_8224_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/76072adf4365/12885_2021_8224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/8316ac0714a2/12885_2021_8224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/90bfcb5fd8fb/12885_2021_8224_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/c0bd90df8586/12885_2021_8224_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/8ce07847b6f5/12885_2021_8224_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/00e2c93a0952/12885_2021_8224_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/76072adf4365/12885_2021_8224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/8316ac0714a2/12885_2021_8224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/90bfcb5fd8fb/12885_2021_8224_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/c0bd90df8586/12885_2021_8224_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/8ce07847b6f5/12885_2021_8224_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba3/8086270/00e2c93a0952/12885_2021_8224_Fig6_HTML.jpg

相似文献

1
Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.文莱达鲁萨兰国结直肠癌患者的生存情况:2002-09 年与 2010-17 年的比较。
BMC Cancer. 2021 Apr 30;21(1):477. doi: 10.1186/s12885-021-08224-6.
2
Survival Rates and Associated Factors of Colorectal Cancer Patients in Brunei Darussalam.文莱达鲁萨兰国结直肠癌患者的生存率及相关因素
Asian Pac J Cancer Prev. 2020 Jan 1;21(1):259-265. doi: 10.31557/APJCP.2020.21.1.259.
3
Characteristics of young colorectal cancer in Brunei Darussalam: an epidemiologic study of 29 years (1986-2014).文莱达鲁萨兰国年轻结直肠癌的特征:一项长达29年(1986 - 2014年)的流行病学研究
Asian Pac J Cancer Prev. 2015;16(8):3279-83. doi: 10.7314/apjcp.2015.16.8.3279.
4
Increasing Incidence of Colorectal Cancer, Starting at a Younger Age for Rectal Compared to Colon Cancer in Brunei Darussalam.文莱达鲁萨兰国结直肠癌发病率上升,直肠癌发病年龄比结肠癌更早。
Asian Pac J Cancer Prev. 2015;16(12):5063-7. doi: 10.7314/apjcp.2015.16.12.5063.
5
Survival of cervical cancer patients in Brunei Darussalam: 2002-2017.文莱达鲁萨兰国宫颈癌患者的生存率:2002 - 2017年
Heliyon. 2023 May 6;9(5):e16080. doi: 10.1016/j.heliyon.2023.e16080. eCollection 2023 May.
6
The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.原发肿瘤侧别对不同分期青年结直肠癌患者生存的影响:一项全国退伍军人事务部的回顾性分析。
Cancer Med. 2021 May;10(9):2987-2995. doi: 10.1002/cam4.3757. Epub 2021 Apr 2.
7
Racial-ethnic colorectal cancer survival disparities in the mountain west region: the case of Blacks compared to Whites.山地西部地区的黑人和白人的种族-民族结直肠癌生存差异:以黑人为例。
Ethn Dis. 2013 Winter;23(1):103-9.
8
Incidence, Mortality and Survival Analysis of Epithelial Ovarian Cancer in Brunei Darussalam.文莱达鲁萨兰国上皮性卵巢癌的发病率、死亡率和生存分析。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1415-1423. doi: 10.31557/APJCP.2022.23.4.1415.
9
Non-Hodgkin lymphoma incidence, mortality, and survival trends in Brunei Darussalam from 2011 to 2020.2011 年至 2020 年文莱达鲁萨兰国非霍奇金淋巴瘤的发病、死亡和生存趋势。
BMC Cancer. 2024 Aug 12;24(1):994. doi: 10.1186/s12885-024-12725-5.
10
Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.马来西亚一家三级医院结直肠癌患者的生存率及生存预测因素
BMC Cancer. 2017 May 18;17(1):339. doi: 10.1186/s12885-017-3336-z.

引用本文的文献

1
Prognostic nomogram for T3-T4 primary colorectal cancer patients with perineural invasion after surgery: a Surveillance, Epidemiology, and End Results program database analysis.T3-T4期伴神经侵犯的原发性结直肠癌患者术后预后列线图:一项监测、流行病学和最终结果计划数据库分析
J Gastrointest Oncol. 2025 Apr 30;16(2):549-567. doi: 10.21037/jgo-24-709. Epub 2025 Apr 27.
2
Temporal trends, disease burden and attributable risk factors of stomach and colorectal cancers among 31 countries and territories in Western Pacific region, 20002021.2000 - 2021年西太平洋地区31个国家和地区胃癌及结直肠癌的时间趋势、疾病负担和可归因风险因素
Chin J Cancer Res. 2025 Apr 30;37(2):187-199. doi: 10.21147/j.issn.1000-9604.2025.02.06.
3

本文引用的文献

1
How we treat left-sided vs right-sided colon cancer.我们如何治疗左半结肠癌与右半结肠癌。
Clin Adv Hematol Oncol. 2020 May;18(5):253-257.
2
IS THERE A DIFFERENCE BETWEEN RIGHT- VERSUS LEFT-SIDED COLON CANCERS? DOES SIDE MAKE ANY DIFFERENCE IN LONG-TERM FOLLOW-UP?右半结肠癌和左半结肠癌之间有差异吗?病变部位对长期随访有影响吗?
Arq Bras Cir Dig. 2019 Dec 20;32(4):e1479. doi: 10.1590/0102-672020190001e1479. eCollection 2019.
3
Dietary patterns and cancer risk.饮食模式与癌症风险。
Early colorectal cancer diagnosis: A novel methylated stool DNA model enhanced the diagnostic efficiency.
早期结直肠癌诊断:一种新型甲基化粪便DNA模型提高了诊断效率。
United European Gastroenterol J. 2025 Apr;13(3):402-415. doi: 10.1002/ueg2.12696. Epub 2024 Nov 2.
4
Mortality rate and predictors of colorectal cancer patients in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚结直肠癌患者的死亡率及其预测因素:系统评价和荟萃分析。
BMC Cancer. 2024 Jul 10;24(1):821. doi: 10.1186/s12885-024-12597-9.
5
Survival Analysis of Lung Cancer patients in Brunei Darussalam.文莱达鲁萨兰国肺癌患者的生存分析。
Asian Pac J Cancer Prev. 2023 Jul 1;24(7):2389-2396. doi: 10.31557/APJCP.2023.24.7.2389.
6
Construction and validation of nomograms combined with novel machine learning algorithms to predict early death of patients with metastatic colorectal cancer.构建并验证列线图联合新型机器学习算法预测转移性结直肠癌患者早期死亡风险。
Front Public Health. 2022 Dec 20;10:1008137. doi: 10.3389/fpubh.2022.1008137. eCollection 2022.
Nat Rev Cancer. 2020 Feb;20(2):125-138. doi: 10.1038/s41568-019-0227-4. Epub 2019 Dec 17.
4
Comparison of clinicopathological and survival features of right and left colon cancers.右半结肠癌与左半结肠癌的临床病理及生存特征比较。
J BUON. 2019 Sep-Oct;24(5):1845-1851.
5
The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年的全球、区域和国家结直肠癌发病和死亡负担及其归因风险因素:基于 2017 年全球疾病负担研究的系统分析
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):913-933. doi: 10.1016/S2468-1253(19)30345-0. Epub 2019 Oct 21.
6
The global challenge of colorectal cancer.结直肠癌的全球挑战。
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):894-895. doi: 10.1016/S2468-1253(19)30329-2. Epub 2019 Oct 21.
7
Impact of tumor sidedness on survival and recurrence patterns in colon cancer patients.肿瘤位置对结肠癌患者生存及复发模式的影响。
Ann Surg Treat Res. 2019 Jun;96(6):296-304. doi: 10.4174/astr.2019.96.6.296. Epub 2019 May 29.
8
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.关联分析确定了 31 个新的结直肠癌易感性风险位点。
Nat Commun. 2019 May 14;10(1):2154. doi: 10.1038/s41467-019-09775-w.
9
Prevalence and risk factors of colorectal cancer in Asia.亚洲结直肠癌的患病率及危险因素
Intest Res. 2019 Jul;17(3):317-329. doi: 10.5217/ir.2019.00021. Epub 2019 May 20.
10
Epidemiology of gastric cancer: global trends, risk factors and prevention.胃癌流行病学:全球趋势、风险因素与预防
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.